Kura Oncology (KURA) News Today $6.44 -0.22 (-3.30%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$6.50 +0.05 (+0.85%) As of 08:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock KURA Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Kura Oncology’s SWOT analysis: ziftomenib’s potential reshapes AML treatment stock outlookJune 15 at 4:08 PM | investing.comKura Oncology and Kyowa Kirin Report Positive Updated Combination Data for Ziftomenib in Newly Diagnosed AML at 2025 European Hematology Association CongressJune 12, 2025 | globenewswire.comLightning Round: 'Wait and see situation' with Papa John's, says Jim CramerJune 12, 2025 | msn.comCantor Fitzgerald Predicts Kura Oncology FY2026 EarningsJune 12, 2025 | americanbankingnews.comBrokers Issue Forecasts for Kura Oncology FY2026 EarningsKura Oncology, Inc. (NASDAQ:KURA - Free Report) - Equities researchers at Cantor Fitzgerald issued their FY2026 earnings per share estimates for shares of Kura Oncology in a research report issued on Monday, June 9th. Cantor Fitzgerald analyst L. Watsek expects that the company will post earningsJune 10, 2025 | marketbeat.comKura Oncology Grants Stock Options To New Hires Under Inducement PlanJune 7, 2025 | nasdaq.comKura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)June 6, 2025 | globenewswire.comJMP Securities Reiterates "Market Outperform" Rating for Kura Oncology (NASDAQ:KURA)JMP Securities reiterated a "market outperform" rating and issued a $28.00 price target on shares of Kura Oncology in a report on Wednesday.June 4, 2025 | marketbeat.comTwo Sigma Investments LP Sells 42,120 Shares of Kura Oncology, Inc. (NASDAQ:KURA)Two Sigma Investments LP lowered its stake in shares of Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 20.2% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 166,119 shares of the company's stock after seJune 4, 2025 | marketbeat.comNuveen Asset Management LLC Lowers Stock Position in Kura Oncology, Inc. (NASDAQ:KURA)Nuveen Asset Management LLC reduced its stake in Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 28.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 182,668 shares of the company's stocJune 4, 2025 | marketbeat.comKura Oncology (NASDAQ:KURA) Shares Gap Up - What's Next?Kura Oncology (NASDAQ:KURA) Shares Gap Up - Should You Buy?June 3, 2025 | marketbeat.comASCO25: Kura’s Phase II ziftomenib results trigger NDA acceptance from FDAJune 3, 2025 | finance.yahoo.comKura Oncology and Kyowa Kirin Report Positive Pivotal Ziftomenib Monotherapy Data at 2025 ASCO Annual MeetingJune 2, 2025 | globenewswire.comFDA Grants Priority Review for Kura Oncology, Inc. (KURA) and Kyowa Kirin’s ZiftomenibJune 2, 2025 | insidermonkey.comSquarepoint Ops LLC Takes $799,000 Position in Kura Oncology, Inc. (NASDAQ:KURA)Squarepoint Ops LLC acquired a new stake in shares of Kura Oncology, Inc. (NASDAQ:KURA - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 91,680 shares of the company's stock, valued at approJune 2, 2025 | marketbeat.comKura Oncology and Kyowa Kirin Announce FDA Acceptance and Priority Review of New Drug Application for Ziftomenib in Adults with Relapsed or Refractory NPM1-Mutant AMLJune 1, 2025 | globenewswire.comKura Oncology, Inc. (NASDAQ:KURA) Shares Acquired by Two Sigma Advisers LPTwo Sigma Advisers LP grew its stake in shares of Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 147.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 242,200 shares of the company'sMay 30, 2025 | marketbeat.comKura Oncology, Inc. (NASDAQ:KURA) Receives Consensus Recommendation of "Moderate Buy" from BrokeragesKura Oncology, Inc. (NASDAQ:KURA - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the fourteen research firms that are covering the firm, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold recommendation, nine have given a buy rMay 30, 2025 | marketbeat.comKura Oncology at TD Cowen Summit: Strategic Innovations in Menin InhibitorsMay 29, 2025 | uk.investing.comCantor Fitzgerald maintains Overweight on Kura Oncology stockMay 26, 2025 | uk.investing.comKura Oncology (NASDAQ:KURA) Trading Down 4.7% - What's Next?Kura Oncology (NASDAQ:KURA) Stock Price Down 4.7% - Should You Sell?May 25, 2025 | marketbeat.comKura Oncology to present trial results for AML treatmentMay 24, 2025 | investing.comRafferty Asset Management LLC Grows Stock Holdings in Kura Oncology, Inc. (NASDAQ:KURA)Rafferty Asset Management LLC raised its holdings in shares of Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 58.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 145,614 shares of the company's stock after acquirMay 24, 2025 | marketbeat.comKura Oncology, Inc. (KURA) and Kyowa Kirin to Present Promising Ziftomenib Data at ASCO 2025May 23, 2025 | insidermonkey.comMillennium Management LLC Buys 1,521,954 Shares of Kura Oncology, Inc. (NASDAQ:KURA)Millennium Management LLC lifted its stake in shares of Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 180.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,367,148 shares of the company's stock after purchasing an aMay 23, 2025 | marketbeat.comKura Oncology and Kyowa Kirin Announce Pivotal Monotherapy Data for Ziftomenib in Oral Presentation at the 2025 ASCO Annual MeetingMay 22, 2025 | globenewswire.comVelan Capital Investment Management LP Buys Shares of 150,000 Kura Oncology, Inc. (NASDAQ:KURA)Velan Capital Investment Management LP acquired a new position in shares of Kura Oncology, Inc. (NASDAQ:KURA - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 150,000 shares of the company'sMay 21, 2025 | marketbeat.comKura Oncology, Inc. (NASDAQ:KURA) Stock Position Raised by BNP Paribas Financial MarketsBNP Paribas Financial Markets lifted its position in Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 969.9% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 163,559 shares of the company's stock after acquiring an additional 1May 21, 2025 | marketbeat.comKura Oncology to Participate in Three Upcoming Investor ConferencesMay 20, 2025 | globenewswire.comLeerink Partnrs Lowers Earnings Estimates for Kura OncologyKura Oncology, Inc. (NASDAQ:KURA - Free Report) - Equities research analysts at Leerink Partnrs decreased their Q3 2025 earnings per share estimates for Kura Oncology in a note issued to investors on Wednesday, May 14th. Leerink Partnrs analyst J. Chang now expects that the company will post earnMay 20, 2025 | marketbeat.comSuvretta Capital Management LLC Lowers Holdings in Kura Oncology, Inc. (NASDAQ:KURA)Suvretta Capital Management LLC decreased its stake in shares of Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 33.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,076,448 shares of the company's stock after selMay 19, 2025 | marketbeat.comGraham Capital Management L.P. Takes $444,000 Position in Kura Oncology, Inc. (NASDAQ:KURA)Graham Capital Management L.P. purchased a new stake in shares of Kura Oncology, Inc. (NASDAQ:KURA - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 50,949 shares of the company's stock, valued atMay 19, 2025 | marketbeat.comProsight Management LP Purchases 619,891 Shares of Kura Oncology, Inc. (NASDAQ:KURA)Prosight Management LP raised its stake in shares of Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 87.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,325,000 shares of the company's stock after puMay 17, 2025 | marketbeat.comD. E. Shaw & Co. Inc. Has $10.03 Million Stock Holdings in Kura Oncology, Inc. (NASDAQ:KURA)D. E. Shaw & Co. Inc. raised its stake in shares of Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 172.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,151,195 shares of the company's stock aftMay 17, 2025 | marketbeat.com977,920 Shares in Kura Oncology, Inc. (NASDAQ:KURA) Bought by Jacobs Levy Equity Management Inc.Jacobs Levy Equity Management Inc. purchased a new position in shares of Kura Oncology, Inc. (NASDAQ:KURA - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 977,920 shares of the company's stoMay 16, 2025 | marketbeat.comVoya Investment Management LLC Decreases Stock Holdings in Kura Oncology, Inc. (NASDAQ:KURA)Voya Investment Management LLC cut its stake in shares of Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 71.4% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 22,016 shares of the company's stock after sellingMay 16, 2025 | marketbeat.comKura Oncology and Kyowa Kirin Announce Combination Data for Ziftomenib in Oral Presentation at the 2025 European Hematology Association (EHA) CongressMay 14, 2025 | globenewswire.comKura Oncology, Inc. (NASDAQ:KURA) Holdings Reduced by Foresite Capital Management IV LLCForesite Capital Management IV LLC lowered its holdings in Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 6.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,726,882 shares of the company's stock after sellingMay 12, 2025 | marketbeat.comDimensional Fund Advisors LP Buys 372,196 Shares of Kura Oncology, Inc. (NASDAQ:KURA)Dimensional Fund Advisors LP boosted its position in shares of Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 35.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,425,960 shares of thMay 12, 2025 | marketbeat.comKura Oncology’s SWOT analysis: ziftomenib’s potential drives stock outlookMay 7, 2025 | investing.comKura Oncology, Inc. (NASDAQ:KURA) Shares Acquired by Algert Global LLCAlgert Global LLC boosted its stake in Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 224.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 883,703 shares of the company's stock after buying an additional 61May 7, 2025 | marketbeat.comBVF Inc. IL Sells 804,292 Shares of Kura Oncology, Inc. (NASDAQ:KURA)BVF Inc. IL reduced its position in Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 23.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,567,469 shares of the company's stock after selling 804,292 shaMay 6, 2025 | marketbeat.comKura Oncology to Participate in Bank of America Securities Healthcare ConferenceMay 6, 2025 | globenewswire.comFY2026 EPS Estimates for Kura Oncology Increased by AnalystKura Oncology, Inc. (NASDAQ:KURA - Free Report) - Stock analysts at Brookline Capital Management boosted their FY2026 earnings per share estimates for Kura Oncology in a research report issued to clients and investors on Thursday, May 1st. Brookline Capital Management analyst L. Cann now anticipaMay 6, 2025 | marketbeat.comKura Oncology, Inc. (NASDAQ:KURA) Given Average Rating of "Moderate Buy" by AnalystsShares of Kura Oncology, Inc. (NASDAQ:KURA - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the thirteen brokerages that are currently covering the stock, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating, eight have gMay 6, 2025 | marketbeat.comKura Oncology (NASDAQ:KURA) Shares Gap Down on Disappointing EarningsKura Oncology (NASDAQ:KURA) Shares Gap Down on Disappointing EarningsMay 4, 2025 | marketbeat.comKura Oncology (NASDAQ:KURA) Price Target Lowered to $11.00 at BarclaysBarclays lowered their price objective on Kura Oncology from $32.00 to $11.00 and set an "overweight" rating for the company in a research report on Friday.May 4, 2025 | marketbeat.comScotiabank Keeps Their Hold Rating on Kura Oncology (KURA)May 4, 2025 | theglobeandmail.comBTIG Keeps Their Hold Rating on Kura Oncology (KURA)May 4, 2025 | theglobeandmail.comKura Oncology, Inc. (NASDAQ:KURA) Shares Acquired by Aquatic Capital Management LLCAquatic Capital Management LLC increased its stake in Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 327.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 79,917 shares of the company's stockMay 4, 2025 | marketbeat.com Get Kura Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for KURA and its competitors with MarketBeat's FREE daily newsletter. Email Address KURA Media Mentions By Week KURA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KURA News Sentiment▼0.880.90▲Average Medical News Sentiment KURA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KURA Articles This Week▼96▲KURA Articles Average Week Get Kura Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for KURA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ARWR News NAMS News RXRX News KNSA News VCEL News DNLI News CGON News HRMY News TWST News BLTE News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KURA) was last updated on 6/16/2025 by MarketBeat.com Staff From Our PartnersAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump Made a Deal. Your Retirement Could Still Be in Danger.America is still barreling toward a financial cliff. This isn't political. It's mathematical. And no trade ...Lear Capital | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | Sponsored[First Look] Get in before potential 10X AI announcementsGo for 10X gains from the next big AI announcement — starting as soon as 7 days from now Former floor trade...Masters in Trading | SponsoredBillionaires are piling into this gold investmentBillionaires Are Piling into a Special Gold Investment With record gold prices, everyday Americans are scra...Weiss Ratings | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kura Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kura Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy KURA Stock Free KURA Stock Alerts